Our strategy is to develop molecular combination based healthcare products that are unique in addressing healthcare needs across a wide spectrum of areas.

These molecular combinations are optimized to work simultaneously on multiple pathways in the disease/symptom network. The Company secures composition of matter and product composition patents on the combinations, and develops novel formulations to deliver innovative, safe, and effective healthcare products.

The rationale for our strategy is based on recent advances in molecular science and related disciplines which have shown that diseases/symptoms involve a network of multiple pathways and targeting a single pathway in such a network using a single molecule may not deliver an efficient therapeutic solution. It is therefore desirable to develop molecular combinations which modulate multiple disease pathways simultaneously to deliver improved therapeutic solutions.

Each of our products meets global pharmaceutical quality standards, and complies with appropriate regulatory requirements.